MPS Powered by Eureka

Current Cardiology Reviews

ISSN: 1573-403X (Print)
eISSN: 1875-6557 (Online)

Journal
Impact Factor :

2.4

Scopus
CiteScore:

3.7

Aims and Scope:Current Cardiology Reviews publishes full-length reviews/mini-reviews and guest edited thematic issues of high quality on all the latest advances on cardiovascular physiology and physiopathology, and on the practical and clinical approach to the diagnosis and treatment of cardiovascular disease, cardiac disease prevention, surgery, and transplantation. All relevant areas are covered by the journal, including arrhythmia, congestive heart failure, cardiomyopathy, congenital heart disease, drugs, methodology, cardiac testing, pacing, medical devices, and preventive cardiology. The journal is essential reading for all researchers and clinicians in cardiology.

Editor-in-Chief:


A. Crisafulli University of Cagliari Cagliari Italy

Indexed in:


Scopus, Scopus, Scopus... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Chronic Disease Self-Management for Heart Failure – A Mini review into Performance Gaps

Chronic disease self-management (CDSM)is a vital component of chronic disease management. There remain several important deficits in this concept. Its benefit are clear, many chronic diseases such as hypertension, diabetes, asthma, rheumatology syndromes have shown benefit in quality of life and quantitative measures of outcomes. Yet, in congestive heart failure early benefits have not translated to current guidelines. This short thematic series on CDSM aims to: firstly provide some understanding on the concept, explore some... see more

Submission closes on: Dec 31, 2025
The era of cardiac medication and implantable devices therapy in heart failure treatment continues

The heart failure (HF) remains a serious public health problem and affects 64 million people worldwide. Although advances in medical therapy and device assistance have significantly improved HF outcomes, the implications of HF are still dramatic. In recent years, innovative developments have been made in HF treatment management, based on robust evidence from drug treatment trials. Furthermore, cardiac resynchronization therapy (CRT) is the therapy with the most proven effectiveness in HF patients with a reduced... see more

Submission closes on: Dec 31, 2025
Advances in Managing Cardiogenic Shock and the Value of Percutaneous Mechanical Circulatory Support.

Despite the advances in cardiology, the outcomes of patients with cardiogenic shock remain poor. There is an increasing interest and use of mechanical circulatory support for patients with cardiogenic shock. Additionally, the complexity of coronary interventions has increased during the last decade with the potential of treating more high-risk patients who benefit from mechanical circulatory support during the intervention. The scope of this thematic issue is to highlight (1) the pathophysiology of cardiogenic shock and... see more